Long-term survival in advanced unresectable HCC treated with transcatheter arterial chemoembolization combined with lenvatinib and PD-1 inhibitors. - Zeng ZX; Song HC; Li YN; Wu JY; Liang D; Li SQ; Zhang ZB; Zhuang SW; Li B; Zhou JY; Liu DY; Li H; et al. (The oncologist, 2025)